top of page
DATE:
TITLE:
ADDITIONAL FORMATS:
10 May 2025
Prof. Sandu Pitaru, Co-founder, CSO, VP R&D & Clin Affairs and Prof. Tanya Gurevich, KOL of MSA, presented interim results of the Phase I clinical study for treating patients with moderate and advanced Multiple System Atrophy (MSA) with hOMSC300 at The International MSA Congress, in Boston 2025.
.png)
Biomed_Linkedin_post
Dr Yona at Biomed
Dr Yona at Biomed2
Biomed_Linkedin_post
1/3
Listen to the podcast
bottom of page